These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4867924)

  • 21. [Self-enhancement in allografts of an aspecific ascitic tumor (ATPC+)].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1967; 27(2):107-22. PubMed ID: 5606081
    [No Abstract]   [Full Text] [Related]  

  • 22. Selection of donors for kidney transplantation.
    Amos DB; Anderson EE; Glenn JF; Gunnells JC; Lancaster SL; MacQueen JM; Robinson RR; Seigler HF; Stickel DL; Ward FE
    Transplant Proc; 1971 Jun; 3(2):993-1003. PubMed ID: 4944053
    [No Abstract]   [Full Text] [Related]  

  • 23. [Extension of the survival of skin xenotransplants with heterologous anti-donor antibodies].
    Castagneto M; Alquati P; Lojacono L; Salerni B
    Chir Patol Sper; 1971 Aug; 19(3):137-50. PubMed ID: 4949664
    [No Abstract]   [Full Text] [Related]  

  • 24. Cluster-forming cells and response to skin allografts.
    Micklem HS; Asfi C; Staines NA
    Transplant Proc; 1971 Mar; 3(1):898-900. PubMed ID: 4937987
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumor-induced accelerated skin graft rejection.
    McCarthy RE; Russfield AB
    Transplantation; 1968 May; 6(3):358-62. PubMed ID: 4871395
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inhibition of the immune reaction following skin allograft by antithymocyte serum therapy of the donors].
    Petrányi G; Szegedi G; Fekete B
    Orv Hetil; 1971 Aug; 112(31):1852-5. PubMed ID: 4941976
    [No Abstract]   [Full Text] [Related]  

  • 27. Passive serologic transfer of immunity to skin grafts in allogeneic and isogeneic mice.
    Kinne DW; Simmons RL
    Rev Surg; 1971; 28(1):68. PubMed ID: 4925865
    [No Abstract]   [Full Text] [Related]  

  • 28. [Donor selection taking into account genetically determined differences in ABO tissue differentiation. 2. The phenomenon of antibody absorption inhibition].
    Delevskiĭ IuP
    Ortop Travmatol Protez; 1972 Sep; 33(9):7-15. PubMed ID: 4569222
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimegts with the "antigen loss factor".
    Ben-Hur N
    Plast Reconstr Surg; 1969 Jan; 43(1):61-5. PubMed ID: 4885277
    [No Abstract]   [Full Text] [Related]  

  • 30. Two phenomena associated with skin grafting from tumor-bearing syngeneic donors.
    Svet-Moldavsky GJ; Mkheidze DM; Liozner AL
    J Natl Cancer Inst; 1967 Jun; 38(6):933-8. PubMed ID: 5338527
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolonged survival of H-2 different skin allografts in mice specifically immunized with lyophilized spleens in Freund's adjuvant.
    Chutná J
    Folia Biol (Praha); 1968; 14(2):140-7. PubMed ID: 4871614
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of immunosuppressive effect of anti-recipient alloantiserum. I. Effect on skin graft survival in mice.
    Dohi K; Asahara T; Ono E; Yahata H; Fukuda Y
    Hiroshima J Med Sci; 1984 Sep; 33(3):507-11. PubMed ID: 6392214
    [No Abstract]   [Full Text] [Related]  

  • 33. Attempts to abolish tolerance of skin homografts in mice with x-irradiated plasma from specifically sensitized donors.
    Lubaroff DM; Silvers WK
    J Immunol; 1971 Apr; 106(4):1122-4. PubMed ID: 4928745
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prolongation of survival of skin homograft with anti-cutaneous immune serum].
    Benkö S; Lázár G; Troján I; Varga L; Petri G
    Orv Hetil; 1969 Dec; 110(52):3047-8. PubMed ID: 4904894
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhanced tumor proliferation in mice treated with phytohaemagglutinin.
    Pappas A; Schwarze G; Wolff C; Scheurlen PG
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 145(5):449-59. PubMed ID: 4282963
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 37. The mechanism of immunological enhancement of H-2-incompatible skin grafts in mice.
    Chutná J
    Transplantation; 1971 Jul; 12(1):28-35. PubMed ID: 4932695
    [No Abstract]   [Full Text] [Related]  

  • 38. MODIFICATION OF THE IMMUNE RESPONSE OF MICE TO SKIN HOMOGRAFTS AND HETEROGRAFTS BY EHRLICH ASCITES CARCINOMA.
    MCCARTHY RE
    Cancer Res; 1964 Jun; 24():915-9. PubMed ID: 14190557
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on homologous transplantation antibodies: homoral and cell-bound antibodies].
    Fujii G; Hirose Y; Goto S; Ishibashi Y; Kozawa T
    Arerugi; 1967 Dec; 16(12):821-31. PubMed ID: 4875541
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations of the effect of horse anti-pig leucocyte serum in suppressing the rejection of skin allografts in pigs.
    Symes MO; Immelman EJ; Lucke JN; Mansell PW
    Folia Biol (Praha); 1969; 15(4):281-7. PubMed ID: 4895951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.